Chan Zuckerberg Initiative's Biohub Announces Fourth Round of Rare As One Funding
The Chan Zuckerberg Initiative’s Biohub is launching its fourth round of funding through the Rare As One Network this fall, targeting patient-led groups working on rare pulmonary and immune diseases as well as rare cancers. The program has already committed over $150 million across four cycles to support research infrastructure and clinical trials for these conditions.
Topics: AI drug repurposing funding initiatives nonprofit research rare diseases